Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Oxycontin makers Purdue Pharma have voted in favour of its bankruptcy reorganisation plan that will provide billions of dollars to repay for its...
A new study has shown that two shots of either Pfizer or AstraZeneca’s COVID-19 vaccine are nearly as effective against the Delta variant as they are...
Roche is discussing its potential treatment, gantenerumab, for Alzheimer's disease with the FDA as clinical trials proceed.
NICE has approved Pemigatinib (Pemazyre) as first treatment for people with a rare form of bile duct cancer (cholangiocarcinoma).
Contract drug manufacturer, Catalent, has announced its $100 million expansion plans for its site in Agnani, Italy, where it is currently filling...
BIAL and Medis have entered into an exclusive partnership on two of Bial's proprietary drugs: its Parkinson’s treatment Ongentys (opicapone) and...
The Government's Chief Scientific Adviser Sir Patrick Vallance has said that 60% of people being admitted to hospital with COVID-19 are unvaccinated.
US state attorneys general are set to unveil a $26 billion settlement this week, aimed at three major drug distributors and drug maker Johnson &...
Researchers have identified a gene, IFI27, that becomes activated in early stages of COVID-19 even when symptoms are absent, helping to identify...
Brits were temporarily unable to order lateral flow COVID-19 test kits on ‘Freedom Day’, the day nearly all restrictions in the UK were lifted.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches